Literature DB >> 3157852

Inhibition of pituitary adenylate cyclase by atrial natriuretic factor.

M B Anand-Srivastava, M Cantin, J Genest.   

Abstract

The effect of synthetic rat atrial natriuretic factor (ANF) on adenylate cyclase activity was studied in rat anterior and posterior pituitary homogenates. ANF (Arg 101-Tyr 126) inhibited adenylate cyclase activity in anterior and posterior pituitary homogenates in a concentration dependent manner. The maximum inhibitions observed were 42% in anterior pituitary with an apparent Ki of 10(-10) M, and 25% with an apparent Ki of 10(-11) M in posterior pituitary. Corticotropin-releasing factor (CRF), vasoactive intestinal peptide (VIP) and prostaglandins (PGE1) stimulated adenylate cyclase to various degrees in anterior pituitary homogenates and ANF inhibited the stimulatory effect of all these hormones. In addition ANF was also able to inhibit the stimulation exerted by NaF and forskolin which activate adenylate cyclase by receptor independent mechanism. Similarly, the stimulatory effects of N-Ethylcarboxamide adenosine (NECA), NaF and forskolin on adenylate cyclase in posterior pituitary homogenates were also inhibited by ANF. This is the first study demonstrating the inhibitory effect of ANF on pituitary adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157852     DOI: 10.1016/0024-3205(85)90161-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

Review 1.  Biologically active atrial peptides.

Authors:  B J Ballerman; B M Brenner
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  Mechanism of vasodilation induced by alpha-human atrial natriuretic polypeptide in rabbit and guinea-pig renal arteries.

Authors:  K Fujii; T Ishimatsu; H Kuriyama
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

3.  Atrial natriuretic factor receptors in rat kidney, adrenal gland, and brain: autoradiographic localization and fluid balance dependent changes.

Authors:  D R Lynch; K M Braas; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Effect of atrial natriuretic peptide on gonadotropin release in superfused rat pituitary cells.

Authors:  J Horvath; T Ertl; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Characterization of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell line.

Authors:  A F Gilkes; P H Ogden; S B Guild; G Cramb
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

6.  The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system.

Authors:  M B Anand-Srivastava; J Gutkowska; M Cantin
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

7.  Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues.

Authors:  C Bianchi; J Gutkowska; G Thibault; R Garcia; J Genest; M Cantin
Journal:  Histochemistry       Date:  1985

8.  Atrial natriuretic peptide and arginine-vasopressin secretion in patients with active renal stone disease.

Authors:  F Kokot; D Klimek; A Wiecek; M Kuczera
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

9.  Characterization of ANF-R2 receptor-mediated inhibition of adenylate cyclase.

Authors:  M B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

10.  Natriuretic peptide receptor mRNAs in the rat and human heart.

Authors:  D J Nunez; M C Dickson; M J Brown
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.